Clarity Pharmaceuticals Email Formats
Biotechnology Research • 
Sydney, New South Wales, Australia • 51-100 Employees
Clarity Pharmaceuticals Email Formats
Clarity Pharmaceuticals uses 5 email formats. The most common is {first initial}.{last name} (e.g., j.doe@claritypharmaceuticals.com), used 36.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@claritypharmaceuticals.com | 36.8% |
{first name}.{last name} | john.doe@claritypharmaceuticals.com | 35.1% |
{first initial} | j@claritypharmaceuticals.com | 14% |
{first initial}{last name} | jdoe@claritypharmaceuticals.com | 8.8% |
{second initial}.{last name} | o.doe@claritypharmaceuticals.com | 3.5% |
Key Contacts at Clarity Pharmaceuticals
Colin Biggin
Coo And Executive Director
Nicollette Pacheco
Director, Medical Affairs
Willie Regits
Senior Director, Supply Chain And Corporate Radiation Safety Officer
Eva Lengyelova
Director Of Clinical Development
Elisa Young
Director, Data Sciences
Laura Lamb
Director Of Clinical Development
Kee Ming Chia
Associate Medical Director
Michelle Parker
Chief Executive Officer & Managing Director
Albert Tondreau
Senior Director, Tct Chemistry
Hannah Billett
Senior Director Clinical Operations
Company overview
| Headquarters | National Innovation Centre, 4 Cornwallis Street, Sydney, NSW 2015, AU |
| Phone number | +61292094037 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Drug Development, Nuclear Medicine, Radiopharmaceuticals, Companion Diagnostics, Targeted Therapy, Antibody And Peptide Imaging, Pharmaceutical Imaging |
| Founded | 2010 |
| Employees | 51-100 |
| Socials |
About Clarity Pharmaceuticals
Clarity is a clinical stage radiopharmaceutical company developing next-generation products to address the growing need for the use of radiopharmaceuticals in oncology. Clarity is a global leader in Targeted Copper Theranostics (TCT), developed with its proprietary SAR Technology platform. TCT are the next-generation disruptive platform in radiopharmaceuticals that employ the “perfect pairing” of copper-64 and copper-67 for diagnosis and therapy. TCT deliver a compelling combination of high accuracy and high precision in the treatment of a range of cancers, as well as providing supply and logistical advantages over current theranostics. TCT provide a highly efficacious, scalable, and cost-effective way to expand radiopharmaceuticals into the global oncology market. Clarity has a diverse range of products in clinical trials which address both large indications (prostate cancer and breast cancer) as well as small and orphan indications (neuroendocrine tumours (NETs) and neuroblastoma) of cancer. Our ultimate goal is to improve treatment outcomes for children and adults with cancer.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Clarity Pharmaceuticals has 38 employees across 10 departments.
Departments
Number of employees
Funding Data
Explore Clarity Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.
Clarity Pharmaceuticals Tech Stack
Discover the technologies and tools that power Clarity Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Programming languages
Blogs
Analytics
Video players
Hosting
SEO
Spain
Canada
Saudi Arabia
Frequently asked questions
4.8
40,000 users
